Synergistic Embolic Capture System for Enhanced Treatment Outcomes

Publication ID: 24-11857209_0008_PTD

Published: November 07, 2025

Category:Synergistic Combinations

Legal Citation

pr1or.art Inc., “Synergistic Embolic Capture System for Enhanced Treatment Outcomes,” Published Technical Disclosure No. 24-11857209_0008_PTD, Published November 07, 2025, available at https://archive.pr1or.art/24-11857209_0008_PTD

This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,209.

Summary of the Inventive Concept

A novel, integrated system for treating blocked blood vessels by combining catheter-based emboli removal with AI, IoT, blockchain, and new materials to enhance treatment efficacy, patient safety, and data management.

Background and Problem Solved

Current mechanical thrombectomy devices have limitations in terms of real-time visualization, data tracking, and personalized treatment. The present inventive concept addresses these limitations by integrating distinct technologies to create a more powerful system for treating blocked blood vessels.

Detailed Description of the Inventive Concept

The synergistic embolic capture system comprises a catheter-based emboli removal system, an AI-powered imaging module for real-time visualization of the vasculature, IoT sensors to monitor blood flow and pressure, a blockchain-based data storage system for tracking treatment outcomes, and new material-based coatings for enhanced biocompatibility. The system enables real-time embolic capture monitoring, personalized thrombectomy, and secure patient data management. The AI-powered predictive model optimizes treatment by integrating data from IoT sensors, and the blockchain-based data storage system ensures secure and transparent tracking of treatment outcomes.

Novelty and Inventive Step

The new claims introduce a synergistic combination of distinct technologies, including AI, IoT, blockchain, and new materials, to create a more powerful system for treating blocked blood vessels. This integration of technologies provides a non-obvious solution to the limitations of current mechanical thrombectomy devices.

Alternative Embodiments and Variations

Alternative embodiments of the inventive concept could include variations in the AI-powered predictive model, IoT sensor configurations, blockchain-based data storage systems, and new material-based coatings. Additionally, the system could be adapted for use in other vascular systems, such as coronary or peripheral vessels.

Potential Commercial Applications and Market

The synergistic embolic capture system has significant commercial potential in the medical device industry, particularly in the areas of neurointerventional and cardiovascular treatment. The system's ability to enhance treatment outcomes, patient safety, and data management makes it an attractive solution for hospitals, clinics, and medical research institutions.

CPC Classifications

Section	Class	Group
A	A61	A61B17/22012
A	A61	A61B17/221
A	A61	A61B2017/22038
A	A61	A61B2017/22084

Section 103 Obviousness Analysis (PHOSITA)

▼

Field of Art

Interventional medical devices, specifically catheter-based embolic capture systems for neurovascular and peripheral vascular treatments, requiring expertise in medical device design, interventional radiology, and minimally invasive surgical techniques

Person of Ordinary Skill (PHOSITA) Profile

A biomedical engineer or interventional radiologist with advanced degree, 5-10 years experience in medical device design, familiar with catheter technologies, vascular imaging, and emerging medical technology integration strategies

Obviousness Rationale

A PHOSITA would recognize that integrating digital technologies like AI, IoT, and blockchain with existing mechanical thrombectomy devices represents a predictable extension of current medical device innovation. The core mechanical embolic capture mechanism remains fundamentally consistent with the source patent, while the proposed technological enhancements represent incremental improvements in monitoring, data management, and treatment personalization. These technological integrations would be considered routine optimization strategies within the medical device engineering domain.

Obvious Combinations & Variations

Source Patent Element

Elongated stent body with axial lumen for embolic capture

PTD Variation

Adding IoT sensors and AI-powered imaging module to monitor embolic capture in real-time

Obviousness Reasoning

Integrating sensor technologies for real-time medical device monitoring is a known technique in interventional medical device design, representing a predictable application of existing technological capabilities

Source Patent Element

Mechanical thrombectomy device for vascular occlusion treatment

PTD Variation

Implementing blockchain-based data storage for tracking treatment outcomes

Obviousness Reasoning

Applying blockchain technology for medical data management is a foreseeable technological progression, representing a standard approach to improving medical record transparency and patient data security

Source Patent Element

Stent body with configurable cell structures

PTD Variation

Neural network-based control system for dynamically adjusting mesh basket configuration

Obviousness Reasoning

Adaptive control systems for medical devices are well-established, and applying machine learning to device configuration represents an obvious technological enhancement within the state of the art

Source Patent Element

Embolic capture device with luminal surface

PTD Variation

Adding new material-based biocompatible coatings to enhance device performance

Obviousness Reasoning

Material science improvements for medical devices are routine design choices, with predictable goals of reducing inflammatory response and improving device integration

35 U.S.C. § 103 Summary: Pursuant to 35 U.S.C. § 103, the variations disclosed in this publication would be considered obvious to a person having ordinary skill in the art at the time of invention, when viewed in light of US Patent 11857209. The proposed technological integrations represent predictable extensions of existing embolic capture device technologies, combining known techniques in medical device design, digital monitoring, and data management to achieve foreseeable improvements in treatment efficacy and patient outcomes.

Original Patent Information

Patent Number	US 11,857,209
Title	Devices and methods for treating blocked blood vessels
Assignee(s)	SHANGHAI WALLABY MEDICAL TECHNOLOGIES CO., INC.